ArticleOncotarget2016

Analysis of ultra-deep targeted sequencing reveals mutation burden is associated with gender and clinical outcome in lung adenocarcinoma.

Dakai Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.